Form 8-K - Current report:
SEC Accession No. 0001104659-23-024436
Filing Date
2023-02-23
Accepted
2023-02-23 06:00:44
Documents
13
Period of Report
2023-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237527d1_8k.htm   iXBRL 8-K 33927
2 EXHIBIT 10.1 tm237527d1_ex10-1.htm EX-10.1 63405
  Complete submission text file 0001104659-23-024436.txt   289858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vygr-20230222.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20230222_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20230222_pre.xml EX-101.PRE 22617
7 EXTRACTED XBRL INSTANCE DOCUMENT tm237527d1_8k_htm.xml XML 3488
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 23655766
SIC: 2836 Biological Products, (No Diagnostic Substances)